Overexpression of NR4A2 alleviates renal and myocardial injury in diabetes nephropathy rats through the HDAC11/SPRY1 pathway.

Xu, Jia; Li, Jinshun; Xu, Xiaohui; Zhu, He; Zhang, Xueli; Yang, Mengru; Ren, Yeping

Xu, Jia; Li, Jinshun; Xu, Xiaohui; Zhu, He; Zhang, Xueli; Yang, Mengru; Ren, Yeping.

Affiliation

Xu J; Department of Nephrology, Shenzhen University General Hospital, Shenzhen University, Shenzhen 518000, Guangdong, China.
Li J; Department of Cardiovasology, South China Hospital, Health Science Center, Shenzhen University, Shenzhen 518116518116, Guangdong, China.
Xu X; Department of Nephrology, Shenzhen University General Hospital, Shenzhen University, Shenzhen 518000, Guangdong, China.
Zhu H; Department of Nephrology, Shenzhen University General Hospital, Shenzhen University, Shenzhen 518000, Guangdong, China.
Zhang X; Department of Nephrology, Shenzhen University General Hospital, Shenzhen University, Shenzhen 518000, Guangdong, China.
Yang M; Department of Nephrology, Shenzhen University General Hospital, Shenzhen University, Shenzhen 518000, Guangdong, China.
Ren Y; Department of Nephrology, Shenzhen University General Hospital, Shenzhen University, Shenzhen 518000, Guangdong, China.

Endocr Metab Immune Disord Drug Targets ; 2022 Oct 21.

Article in En | MEDLINE | ID: mdl-36281860

Key words

CK-MB; H3K27ac; HDAC11; NR4A2; SPRY1; cardiac function; diabetic nephropathy; inflammation; renal function

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Endocr Metab Immune Disord Drug Targets Journal subject: ALERGIA E IMUNOLOGIA / ENDOCRINOLOGIA / METABOLISMO / TERAPIA POR MEDICAMENTOS Year: 2022 Document type: Article Affiliation country: China Country of publication: United Arab Emirates

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google